nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—SLC22A5—Dactinomycin—uterine cancer	0.199	0.442	CbGbCtD
Furosemide—ABCC2—Carboplatin—uterine cancer	0.104	0.231	CbGbCtD
Furosemide—ABCC2—Etoposide—uterine cancer	0.0875	0.194	CbGbCtD
Furosemide—ABCC2—Doxorubicin—uterine cancer	0.0597	0.132	CbGbCtD
Furosemide—CA6—exocrine gland—uterine cancer	0.0104	0.0681	CbGeAlD
Furosemide—CA5A—female reproductive system—uterine cancer	0.00521	0.0341	CbGeAlD
Furosemide—CA7—renal system—uterine cancer	0.00433	0.0283	CbGeAlD
Furosemide—SLCO2A1—myometrium—uterine cancer	0.00411	0.0269	CbGeAlD
Furosemide—PGD—myometrium—uterine cancer	0.00366	0.024	CbGeAlD
Furosemide—CA2—exocrine gland—uterine cancer	0.00358	0.0234	CbGeAlD
Furosemide—SLC12A1—epithelium—uterine cancer	0.00349	0.0229	CbGeAlD
Furosemide—SLC22A11—renal system—uterine cancer	0.00333	0.0218	CbGeAlD
Furosemide—SLC12A1—renal system—uterine cancer	0.00324	0.0212	CbGeAlD
Furosemide—SLCO2A1—epithelium—uterine cancer	0.00322	0.0211	CbGeAlD
Furosemide—SLCO2A1—uterine cervix—uterine cancer	0.00319	0.0209	CbGeAlD
Furosemide—CA9—female reproductive system—uterine cancer	0.00305	0.0199	CbGeAlD
Furosemide—SLCO2A1—decidua—uterine cancer	0.00304	0.0199	CbGeAlD
Furosemide—SLCO2A1—renal system—uterine cancer	0.00299	0.0196	CbGeAlD
Furosemide—SLCO2A1—endometrium—uterine cancer	0.00289	0.0189	CbGeAlD
Furosemide—PGD—uterine cervix—uterine cancer	0.00285	0.0186	CbGeAlD
Furosemide—CA12—renal system—uterine cancer	0.00281	0.0184	CbGeAlD
Furosemide—SLCO2A1—mammalian vulva—uterine cancer	0.0028	0.0183	CbGeAlD
Furosemide—PGD—smooth muscle tissue—uterine cancer	0.00277	0.0181	CbGeAlD
Furosemide—PGD—decidua—uterine cancer	0.00271	0.0178	CbGeAlD
Furosemide—SLC22A11—female reproductive system—uterine cancer	0.00267	0.0175	CbGeAlD
Furosemide—PGD—renal system—uterine cancer	0.00266	0.0174	CbGeAlD
Furosemide—SLCO2A1—uterus—uterine cancer	0.00266	0.0174	CbGeAlD
Furosemide—PGD—endometrium—uterine cancer	0.00258	0.0169	CbGeAlD
Furosemide—PGD—mammalian vulva—uterine cancer	0.00249	0.0163	CbGeAlD
Furosemide—SLCO2A1—female reproductive system—uterine cancer	0.00239	0.0157	CbGeAlD
Furosemide—PGD—uterus—uterine cancer	0.00237	0.0155	CbGeAlD
Furosemide—CA5B—mammalian vulva—uterine cancer	0.00236	0.0154	CbGeAlD
Furosemide—CA12—female reproductive system—uterine cancer	0.00225	0.0147	CbGeAlD
Furosemide—CA1—renal system—uterine cancer	0.00223	0.0146	CbGeAlD
Furosemide—SLCO2A1—female gonad—uterine cancer	0.00218	0.0143	CbGeAlD
Furosemide—SLCO2A1—vagina—uterine cancer	0.00216	0.0142	CbGeAlD
Furosemide—PGD—female reproductive system—uterine cancer	0.00213	0.014	CbGeAlD
Furosemide—CA5B—female reproductive system—uterine cancer	0.00202	0.0132	CbGeAlD
Furosemide—SLC22A5—myometrium—uterine cancer	0.00195	0.0128	CbGeAlD
Furosemide—PGD—female gonad—uterine cancer	0.00194	0.0127	CbGeAlD
Furosemide—PGD—vagina—uterine cancer	0.00193	0.0126	CbGeAlD
Furosemide—SLC22A8—renal system—uterine cancer	0.00188	0.0123	CbGeAlD
Furosemide—ABCC2—renal system—uterine cancer	0.00183	0.012	CbGeAlD
Furosemide—CA5B—vagina—uterine cancer	0.00183	0.012	CbGeAlD
Furosemide—CA1—female reproductive system—uterine cancer	0.00178	0.0117	CbGeAlD
Furosemide—CA4—renal system—uterine cancer	0.00174	0.0114	CbGeAlD
Furosemide—CA2—epithelium—uterine cancer	0.00156	0.0102	CbGeAlD
Furosemide—SLC22A5—uterine cervix—uterine cancer	0.00152	0.00994	CbGeAlD
Furosemide—CA2—smooth muscle tissue—uterine cancer	0.0015	0.00982	CbGeAlD
Furosemide—CA2—decidua—uterine cancer	0.00147	0.00963	CbGeAlD
Furosemide—ABCC2—female reproductive system—uterine cancer	0.00147	0.00962	CbGeAlD
Furosemide—CA2—renal system—uterine cancer	0.00144	0.00946	CbGeAlD
Furosemide—SLC22A5—renal system—uterine cancer	0.00142	0.0093	CbGeAlD
Furosemide—SLCO2A1—lymph node—uterine cancer	0.0014	0.00917	CbGeAlD
Furosemide—CA4—female reproductive system—uterine cancer	0.00139	0.00913	CbGeAlD
Furosemide—SLC22A5—endometrium—uterine cancer	0.00137	0.00899	CbGeAlD
Furosemide—CA2—mammalian vulva—uterine cancer	0.00135	0.00884	CbGeAlD
Furosemide—CA4—female gonad—uterine cancer	0.00127	0.00831	CbGeAlD
Furosemide—PGD—lymph node—uterine cancer	0.00125	0.00817	CbGeAlD
Furosemide—CA5B—lymph node—uterine cancer	0.00118	0.00774	CbGeAlD
Furosemide—CA2—female reproductive system—uterine cancer	0.00116	0.00757	CbGeAlD
Furosemide—SLC22A5—female reproductive system—uterine cancer	0.00114	0.00745	CbGeAlD
Furosemide—CA2—female gonad—uterine cancer	0.00105	0.00689	CbGeAlD
Furosemide—CA2—vagina—uterine cancer	0.00105	0.00685	CbGeAlD
Furosemide—CA1—lymph node—uterine cancer	0.00104	0.00684	CbGeAlD
Furosemide—SLC22A5—female gonad—uterine cancer	0.00104	0.00678	CbGeAlD
Furosemide—SLC22A5—vagina—uterine cancer	0.00103	0.00674	CbGeAlD
Furosemide—ALB—lymph node—uterine cancer	0.000917	0.006	CbGeAlD
Furosemide—ABCC2—lymph node—uterine cancer	0.000859	0.00563	CbGeAlD
Furosemide—CA4—lymph node—uterine cancer	0.000816	0.00534	CbGeAlD
Furosemide—CA2—lymph node—uterine cancer	0.000677	0.00443	CbGeAlD
Furosemide—SLC22A5—lymph node—uterine cancer	0.000666	0.00436	CbGeAlD
Furosemide—Aplastic anaemia—Epirubicin—uterine cancer	0.000646	0.00163	CcSEcCtD
Furosemide—Agranulocytosis—Etoposide—uterine cancer	0.000641	0.00161	CcSEcCtD
Furosemide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000639	0.00161	CcSEcCtD
Furosemide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000634	0.0016	CcSEcCtD
Furosemide—Cramps of lower extremities—Epirubicin—uterine cancer	0.000632	0.00159	CcSEcCtD
Furosemide—Hypersensitivity—Progesterone—uterine cancer	0.00063	0.00159	CcSEcCtD
Furosemide—Bladder pain—Epirubicin—uterine cancer	0.000622	0.00157	CcSEcCtD
Furosemide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000616	0.00155	CcSEcCtD
Furosemide—Asthenia—Progesterone—uterine cancer	0.000614	0.00155	CcSEcCtD
Furosemide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000613	0.00155	CcSEcCtD
Furosemide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000613	0.00155	CcSEcCtD
Furosemide—Urinary tract disorder—Etoposide—uterine cancer	0.000608	0.00153	CcSEcCtD
Furosemide—Pruritus—Progesterone—uterine cancer	0.000605	0.00153	CcSEcCtD
Furosemide—Urethral disorder—Etoposide—uterine cancer	0.000604	0.00152	CcSEcCtD
Furosemide—Aplastic anaemia—Doxorubicin—uterine cancer	0.000597	0.00151	CcSEcCtD
Furosemide—Mental disability—Epirubicin—uterine cancer	0.000597	0.0015	CcSEcCtD
Furosemide—Thrombocytopenia—Dactinomycin—uterine cancer	0.000592	0.00149	CcSEcCtD
Furosemide—Diarrhoea—Progesterone—uterine cancer	0.000586	0.00148	CcSEcCtD
Furosemide—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000585	0.00147	CcSEcCtD
Furosemide—Erythema multiforme—Etoposide—uterine cancer	0.000583	0.00147	CcSEcCtD
Furosemide—Thrombophlebitis—Epirubicin—uterine cancer	0.000577	0.00145	CcSEcCtD
Furosemide—Anorexia—Dactinomycin—uterine cancer	0.000577	0.00145	CcSEcCtD
Furosemide—Eye disorder—Etoposide—uterine cancer	0.000576	0.00145	CcSEcCtD
Furosemide—Bladder pain—Doxorubicin—uterine cancer	0.000575	0.00145	CcSEcCtD
Furosemide—Diabetes mellitus—Epirubicin—uterine cancer	0.000574	0.00145	CcSEcCtD
Furosemide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000571	0.00144	CcSEcCtD
Furosemide—Photosensitivity—Epirubicin—uterine cancer	0.000569	0.00143	CcSEcCtD
Furosemide—Dizziness—Progesterone—uterine cancer	0.000566	0.00143	CcSEcCtD
Furosemide—Angiopathy—Etoposide—uterine cancer	0.000559	0.00141	CcSEcCtD
Furosemide—Vascular purpura—Epirubicin—uterine cancer	0.000558	0.00141	CcSEcCtD
Furosemide—Immune system disorder—Etoposide—uterine cancer	0.000557	0.0014	CcSEcCtD
Furosemide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.0014	CcSEcCtD
Furosemide—Mental disability—Doxorubicin—uterine cancer	0.000552	0.00139	CcSEcCtD
Furosemide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000549	0.00138	CcSEcCtD
Furosemide—Vomiting—Progesterone—uterine cancer	0.000544	0.00137	CcSEcCtD
Furosemide—Rash—Progesterone—uterine cancer	0.00054	0.00136	CcSEcCtD
Furosemide—Dermatitis—Progesterone—uterine cancer	0.000539	0.00136	CcSEcCtD
Furosemide—Headache—Progesterone—uterine cancer	0.000536	0.00135	CcSEcCtD
Furosemide—Thrombophlebitis—Doxorubicin—uterine cancer	0.000534	0.00135	CcSEcCtD
Furosemide—Diabetes mellitus—Doxorubicin—uterine cancer	0.000531	0.00134	CcSEcCtD
Furosemide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000531	0.00134	CcSEcCtD
Furosemide—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000529	0.00133	CcSEcCtD
Furosemide—Photosensitivity—Doxorubicin—uterine cancer	0.000526	0.00133	CcSEcCtD
Furosemide—Decreased appetite—Dactinomycin—uterine cancer	0.000526	0.00133	CcSEcCtD
Furosemide—Dysgeusia—Etoposide—uterine cancer	0.000525	0.00132	CcSEcCtD
Furosemide—Dermatitis bullous—Epirubicin—uterine cancer	0.000522	0.00132	CcSEcCtD
Furosemide—Fatigue—Dactinomycin—uterine cancer	0.000521	0.00131	CcSEcCtD
Furosemide—Purpura—Epirubicin—uterine cancer	0.000518	0.00131	CcSEcCtD
Furosemide—Pain—Dactinomycin—uterine cancer	0.000517	0.0013	CcSEcCtD
Furosemide—Vascular purpura—Doxorubicin—uterine cancer	0.000516	0.0013	CcSEcCtD
Furosemide—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000516	0.0013	CcSEcCtD
Furosemide—Muscle spasms—Etoposide—uterine cancer	0.000516	0.0013	CcSEcCtD
Furosemide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000513	0.00129	CcSEcCtD
Furosemide—Lethargy—Epirubicin—uterine cancer	0.000509	0.00128	CcSEcCtD
Furosemide—Nausea—Progesterone—uterine cancer	0.000508	0.00128	CcSEcCtD
Furosemide—Hyponatraemia—Epirubicin—uterine cancer	0.000501	0.00126	CcSEcCtD
Furosemide—Feeling abnormal—Dactinomycin—uterine cancer	0.000498	0.00126	CcSEcCtD
Furosemide—Anaemia—Etoposide—uterine cancer	0.000496	0.00125	CcSEcCtD
Furosemide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000495	0.00125	CcSEcCtD
Furosemide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000493	0.00124	CcSEcCtD
Furosemide—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00049	0.00123	CcSEcCtD
Furosemide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000489	0.00123	CcSEcCtD
Furosemide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000488	0.00123	CcSEcCtD
Furosemide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.00122	CcSEcCtD
Furosemide—Dermatitis bullous—Doxorubicin—uterine cancer	0.000483	0.00122	CcSEcCtD
Furosemide—Vertigo—Etoposide—uterine cancer	0.000482	0.00121	CcSEcCtD
Furosemide—Leukopenia—Etoposide—uterine cancer	0.00048	0.00121	CcSEcCtD
Furosemide—Purpura—Doxorubicin—uterine cancer	0.000479	0.00121	CcSEcCtD
Furosemide—Abdominal pain—Dactinomycin—uterine cancer	0.000478	0.00121	CcSEcCtD
Furosemide—Body temperature increased—Dactinomycin—uterine cancer	0.000478	0.00121	CcSEcCtD
Furosemide—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000477	0.0012	CcSEcCtD
Furosemide—Lethargy—Doxorubicin—uterine cancer	0.000471	0.00119	CcSEcCtD
Furosemide—Blood creatinine increased—Epirubicin—uterine cancer	0.000468	0.00118	CcSEcCtD
Furosemide—Dehydration—Epirubicin—uterine cancer	0.000464	0.00117	CcSEcCtD
Furosemide—Hyponatraemia—Doxorubicin—uterine cancer	0.000464	0.00117	CcSEcCtD
Furosemide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000461	0.00116	CcSEcCtD
Furosemide—Orthostatic hypotension—Epirubicin—uterine cancer	0.000456	0.00115	CcSEcCtD
Furosemide—Hypokalaemia—Epirubicin—uterine cancer	0.000454	0.00115	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000454	0.00114	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00045	0.00113	CcSEcCtD
Furosemide—Hypersensitivity—Dactinomycin—uterine cancer	0.000446	0.00112	CcSEcCtD
Furosemide—Confusional state—Etoposide—uterine cancer	0.000441	0.00111	CcSEcCtD
Furosemide—Muscular weakness—Epirubicin—uterine cancer	0.00044	0.00111	CcSEcCtD
Furosemide—Anaphylactic shock—Etoposide—uterine cancer	0.000438	0.0011	CcSEcCtD
Furosemide—Abdominal distension—Epirubicin—uterine cancer	0.000434	0.0011	CcSEcCtD
Furosemide—Asthenia—Dactinomycin—uterine cancer	0.000434	0.00109	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—uterine cancer	0.000433	0.00109	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—uterine cancer	0.00043	0.00108	CcSEcCtD
Furosemide—Thrombocytopenia—Etoposide—uterine cancer	0.000429	0.00108	CcSEcCtD
Furosemide—Eosinophilia—Epirubicin—uterine cancer	0.000427	0.00108	CcSEcCtD
Furosemide—Skin disorder—Etoposide—uterine cancer	0.000425	0.00107	CcSEcCtD
Furosemide—Hyperhidrosis—Etoposide—uterine cancer	0.000423	0.00107	CcSEcCtD
Furosemide—Pancreatitis—Epirubicin—uterine cancer	0.000423	0.00107	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000422	0.00106	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—uterine cancer	0.00042	0.00106	CcSEcCtD
Furosemide—Anorexia—Etoposide—uterine cancer	0.000417	0.00105	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000416	0.00105	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—uterine cancer	0.000414	0.00104	CcSEcCtD
Furosemide—Hypotension—Etoposide—uterine cancer	0.000409	0.00103	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—uterine cancer	0.000407	0.00103	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—uterine cancer	0.000402	0.00101	CcSEcCtD
Furosemide—Pollakiuria—Epirubicin—uterine cancer	0.000399	0.001	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—uterine cancer	0.000395	0.000997	CcSEcCtD
Furosemide—Photosensitivity reaction—Epirubicin—uterine cancer	0.000394	0.000993	CcSEcCtD
Furosemide—Paraesthesia—Etoposide—uterine cancer	0.000393	0.000991	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—uterine cancer	0.000391	0.000987	CcSEcCtD
Furosemide—Hyperglycaemia—Epirubicin—uterine cancer	0.000389	0.000981	CcSEcCtD
Furosemide—Somnolence—Etoposide—uterine cancer	0.000389	0.000981	CcSEcCtD
Furosemide—Drowsiness—Epirubicin—uterine cancer	0.000385	0.00097	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—uterine cancer	0.000385	0.000969	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000381	0.000962	CcSEcCtD
Furosemide—Rash—Dactinomycin—uterine cancer	0.000381	0.000961	CcSEcCtD
Furosemide—Decreased appetite—Etoposide—uterine cancer	0.000381	0.000959	CcSEcCtD
Furosemide—Renal failure—Epirubicin—uterine cancer	0.000378	0.000953	CcSEcCtD
Furosemide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000378	0.000953	CcSEcCtD
Furosemide—Fatigue—Etoposide—uterine cancer	0.000377	0.000951	CcSEcCtD
Furosemide—Constipation—Etoposide—uterine cancer	0.000374	0.000944	CcSEcCtD
Furosemide—Pain—Etoposide—uterine cancer	0.000374	0.000944	CcSEcCtD
Furosemide—Sweating—Epirubicin—uterine cancer	0.000369	0.00093	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—uterine cancer	0.000369	0.00093	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000364	0.000919	CcSEcCtD
Furosemide—Hepatobiliary disease—Epirubicin—uterine cancer	0.000364	0.000917	CcSEcCtD
Furosemide—Feeling abnormal—Etoposide—uterine cancer	0.000361	0.000909	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—uterine cancer	0.00036	0.000908	CcSEcCtD
Furosemide—Nausea—Dactinomycin—uterine cancer	0.000359	0.000906	CcSEcCtD
Furosemide—Agranulocytosis—Epirubicin—uterine cancer	0.000359	0.000905	CcSEcCtD
Furosemide—Gastrointestinal pain—Etoposide—uterine cancer	0.000358	0.000902	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—uterine cancer	0.000356	0.000897	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000353	0.00089	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—uterine cancer	0.00035	0.000882	CcSEcCtD
Furosemide—Urticaria—Etoposide—uterine cancer	0.000348	0.000877	CcSEcCtD
Furosemide—Abdominal pain—Etoposide—uterine cancer	0.000346	0.000872	CcSEcCtD
Furosemide—Body temperature increased—Etoposide—uterine cancer	0.000346	0.000872	CcSEcCtD
Furosemide—Sweating—Doxorubicin—uterine cancer	0.000341	0.00086	CcSEcCtD
Furosemide—Urinary tract disorder—Epirubicin—uterine cancer	0.000341	0.00086	CcSEcCtD
Furosemide—Urethral disorder—Epirubicin—uterine cancer	0.000339	0.000854	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000337	0.000849	CcSEcCtD
Furosemide—Visual impairment—Epirubicin—uterine cancer	0.000333	0.000839	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—uterine cancer	0.000332	0.000837	CcSEcCtD
Furosemide—Erythema multiforme—Epirubicin—uterine cancer	0.000327	0.000823	CcSEcCtD
Furosemide—Eye disorder—Epirubicin—uterine cancer	0.000323	0.000814	CcSEcCtD
Furosemide—Hypersensitivity—Etoposide—uterine cancer	0.000323	0.000813	CcSEcCtD
Furosemide—Tinnitus—Epirubicin—uterine cancer	0.000322	0.000812	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—uterine cancer	0.000316	0.000796	CcSEcCtD
Furosemide—Asthenia—Etoposide—uterine cancer	0.000314	0.000792	CcSEcCtD
Furosemide—Angiopathy—Epirubicin—uterine cancer	0.000313	0.00079	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—uterine cancer	0.000313	0.00079	CcSEcCtD
Furosemide—Immune system disorder—Epirubicin—uterine cancer	0.000312	0.000786	CcSEcCtD
Furosemide—Pruritus—Etoposide—uterine cancer	0.00031	0.000781	CcSEcCtD
Furosemide—Arrhythmia—Epirubicin—uterine cancer	0.000309	0.000778	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—uterine cancer	0.000308	0.000776	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—uterine cancer	0.000302	0.000762	CcSEcCtD
Furosemide—Erythema—Epirubicin—uterine cancer	0.000301	0.000758	CcSEcCtD
Furosemide—Malnutrition—Epirubicin—uterine cancer	0.000301	0.000758	CcSEcCtD
Furosemide—Diarrhoea—Etoposide—uterine cancer	0.0003	0.000755	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—uterine cancer	0.000299	0.000753	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—uterine cancer	0.000298	0.000751	CcSEcCtD
Furosemide—Flatulence—Epirubicin—uterine cancer	0.000296	0.000747	CcSEcCtD
Furosemide—Dysgeusia—Epirubicin—uterine cancer	0.000294	0.000742	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—uterine cancer	0.00029	0.000731	CcSEcCtD
Furosemide—Dizziness—Etoposide—uterine cancer	0.000289	0.00073	CcSEcCtD
Furosemide—Muscle spasms—Epirubicin—uterine cancer	0.000289	0.000729	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—uterine cancer	0.000289	0.000728	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—uterine cancer	0.000285	0.00072	CcSEcCtD
Furosemide—Vision blurred—Epirubicin—uterine cancer	0.000283	0.000714	CcSEcCtD
Furosemide—Vomiting—Etoposide—uterine cancer	0.000278	0.000702	CcSEcCtD
Furosemide—Erythema—Doxorubicin—uterine cancer	0.000278	0.000701	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—uterine cancer	0.000278	0.000701	CcSEcCtD
Furosemide—Anaemia—Epirubicin—uterine cancer	0.000278	0.000701	CcSEcCtD
Furosemide—Agitation—Epirubicin—uterine cancer	0.000276	0.000697	CcSEcCtD
Furosemide—Rash—Etoposide—uterine cancer	0.000276	0.000696	CcSEcCtD
Furosemide—Dermatitis—Etoposide—uterine cancer	0.000276	0.000695	CcSEcCtD
Furosemide—Headache—Etoposide—uterine cancer	0.000274	0.000691	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—uterine cancer	0.000274	0.000691	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—uterine cancer	0.000272	0.000687	CcSEcCtD
Furosemide—Vertigo—Epirubicin—uterine cancer	0.00027	0.000681	CcSEcCtD
Furosemide—Leukopenia—Epirubicin—uterine cancer	0.000269	0.000678	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—uterine cancer	0.000267	0.000674	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—uterine cancer	0.000262	0.000661	CcSEcCtD
Furosemide—Nausea—Etoposide—uterine cancer	0.00026	0.000655	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—uterine cancer	0.000257	0.000648	CcSEcCtD
Furosemide—Agitation—Doxorubicin—uterine cancer	0.000256	0.000644	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000254	0.000641	CcSEcCtD
Furosemide—Dry mouth—Epirubicin—uterine cancer	0.00025	0.000631	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—uterine cancer	0.00025	0.00063	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—uterine cancer	0.000249	0.000628	CcSEcCtD
Furosemide—Confusional state—Epirubicin—uterine cancer	0.000247	0.000624	CcSEcCtD
Furosemide—Anaphylactic shock—Epirubicin—uterine cancer	0.000245	0.000619	CcSEcCtD
Furosemide—Shock—Epirubicin—uterine cancer	0.000241	0.000609	CcSEcCtD
Furosemide—Nervous system disorder—Epirubicin—uterine cancer	0.000241	0.000607	CcSEcCtD
Furosemide—Thrombocytopenia—Epirubicin—uterine cancer	0.00024	0.000606	CcSEcCtD
Furosemide—Skin disorder—Epirubicin—uterine cancer	0.000238	0.000601	CcSEcCtD
Furosemide—Hyperhidrosis—Epirubicin—uterine cancer	0.000237	0.000598	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000235	0.000593	CcSEcCtD
Furosemide—Anorexia—Epirubicin—uterine cancer	0.000234	0.00059	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—uterine cancer	0.000232	0.000584	CcSEcCtD
Furosemide—Hypotension—Epirubicin—uterine cancer	0.000229	0.000578	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—uterine cancer	0.000229	0.000577	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—uterine cancer	0.000227	0.000572	CcSEcCtD
Furosemide—Shock—Doxorubicin—uterine cancer	0.000223	0.000563	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—uterine cancer	0.000223	0.000561	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000222	0.00056	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—uterine cancer	0.000221	0.000556	CcSEcCtD
Furosemide—Paraesthesia—Epirubicin—uterine cancer	0.00022	0.000555	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000219	0.000553	CcSEcCtD
Furosemide—Somnolence—Epirubicin—uterine cancer	0.000218	0.00055	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—uterine cancer	0.000216	0.000546	CcSEcCtD
Furosemide—Decreased appetite—Epirubicin—uterine cancer	0.000213	0.000538	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—uterine cancer	0.000212	0.000535	CcSEcCtD
Furosemide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000212	0.000534	CcSEcCtD
Furosemide—Fatigue—Epirubicin—uterine cancer	0.000212	0.000533	CcSEcCtD
Furosemide—Pain—Epirubicin—uterine cancer	0.00021	0.000529	CcSEcCtD
Furosemide—Constipation—Epirubicin—uterine cancer	0.00021	0.000529	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—uterine cancer	0.000204	0.000514	CcSEcCtD
Furosemide—Feeling abnormal—Epirubicin—uterine cancer	0.000202	0.00051	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—uterine cancer	0.000202	0.000509	CcSEcCtD
Furosemide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000201	0.000506	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—uterine cancer	0.000197	0.000498	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000196	0.000494	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—uterine cancer	0.000196	0.000493	CcSEcCtD
Furosemide—Urticaria—Epirubicin—uterine cancer	0.000195	0.000491	CcSEcCtD
Furosemide—Constipation—Doxorubicin—uterine cancer	0.000194	0.000489	CcSEcCtD
Furosemide—Pain—Doxorubicin—uterine cancer	0.000194	0.000489	CcSEcCtD
Furosemide—Abdominal pain—Epirubicin—uterine cancer	0.000194	0.000489	CcSEcCtD
Furosemide—Body temperature increased—Epirubicin—uterine cancer	0.000194	0.000489	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—uterine cancer	0.000187	0.000472	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000186	0.000468	CcSEcCtD
Furosemide—Hypersensitivity—Epirubicin—uterine cancer	0.000181	0.000456	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—uterine cancer	0.00018	0.000455	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—uterine cancer	0.000179	0.000452	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—uterine cancer	0.000179	0.000452	CcSEcCtD
Furosemide—Asthenia—Epirubicin—uterine cancer	0.000176	0.000444	CcSEcCtD
Furosemide—Pruritus—Epirubicin—uterine cancer	0.000174	0.000438	CcSEcCtD
Furosemide—Diarrhoea—Epirubicin—uterine cancer	0.000168	0.000423	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—uterine cancer	0.000167	0.000422	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—uterine cancer	0.000163	0.000411	CcSEcCtD
Furosemide—Dizziness—Epirubicin—uterine cancer	0.000162	0.000409	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—uterine cancer	0.000161	0.000405	CcSEcCtD
Furosemide—Vomiting—Epirubicin—uterine cancer	0.000156	0.000393	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—uterine cancer	0.000155	0.000392	CcSEcCtD
Furosemide—Rash—Epirubicin—uterine cancer	0.000155	0.00039	CcSEcCtD
Furosemide—Dermatitis—Epirubicin—uterine cancer	0.000155	0.00039	CcSEcCtD
Furosemide—Headache—Epirubicin—uterine cancer	0.000154	0.000388	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—uterine cancer	0.00015	0.000378	CcSEcCtD
Furosemide—Nausea—Epirubicin—uterine cancer	0.000146	0.000367	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—uterine cancer	0.000144	0.000364	CcSEcCtD
Furosemide—Rash—Doxorubicin—uterine cancer	0.000143	0.000361	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—uterine cancer	0.000143	0.000361	CcSEcCtD
Furosemide—Headache—Doxorubicin—uterine cancer	0.000142	0.000359	CcSEcCtD
Furosemide—Nausea—Doxorubicin—uterine cancer	0.000135	0.00034	CcSEcCtD
